Last reviewed · How we verify
NCT05290272
Validity of AI in Treatment of the Musculoskeletal Conditions by Vifive
NA trial testing ViFIVE Digital Care Progrma in Shoulder Adhesive Capsulitis in 35 participants. Completed in 6 June 2024.
6 June 2024
Quick facts
| Lead sponsor | Stanford University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 35 |
| Start date | 30 January 2023 |
| Primary completion | 6 June 2024 |
| Estimated completion | 6 June 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- ViFIVE Digital Care Progrma
Conditions studied
- Shoulder Adhesive Capsulitis — all drugs for Shoulder Adhesive Capsulitis →
- Knee Osteoarthritis — all drugs for Knee Osteoarthritis →
Sponsor
Stanford University
Who can join
Adults 18 to 70, any sex, with Shoulder Adhesive Capsulitis or Knee Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to evaluate the efficacy of the 12-week ViFive program, a vision-based artificial intelligent digital care plan for chronic knee pain. ViFive digital care plan is delivered by a physical therapy team consisting of physical therapists and a personal coach. We aim to understand the safety and efficacy of this vision artificial intelligent based home exercise program.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Digital therapeutics in the clinic.
Phan P, Mitragotri S, Zhao Z. · · 2023 · cited 39× · PMID 37476062 · DOI 10.1002/btm2.10536
Verify or expand the search:
- PubMed search for NCT05290272
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Shoulder Adhesive Capsulitis
Currently open trials in the same condition.
- NCT07336849 — Transcatheter Arterial Embolization Using Nexsphere-F for Chronic Shoulder Pain Refractory to Conservative Treatment · NA · recruiting
- NCT07236658 — Deep Learning for Musculoskeletal Complications in Breast Cancer · recruiting
Other Stanford University trials
Trials by the same sponsor.
- NCT05945147 — Ketamine and Midazolam Infusions for CRPS: Feasibility Study · Phase 2 · withdrawn
- NCT04225949 — Patients Understanding of PROM Graphs · NA · withdrawn
- NCT06273098 — School-Based Bladder Health Intervention · NA · withdrawn
- NCT04652635 — Management of Nailbed Injuries · NA · withdrawn
- NCT05443503 — Stanford Spine Keeper - Managing Your Low Back Pain · NA · suspended
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05290272 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Stanford University
- Last refreshed: 22 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05290272.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing